Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
100%(2 trials)

Phase Distribution

Ph phase_1
1
25%
Ph phase_3
1
25%
Ph phase_2
2
50%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(2)

Detailed Status

Completed2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (25.0%)
Phase 22 (50.0%)
Phase 31 (25.0%)

Trials by Status

completed250%
withdrawn250%

Recent Activity

0 active trials
Showing 4 of 4
withdrawnphase_3

GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis

NCT03202004
withdrawnphase_1

A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects

NCT03201978
completedphase_2

A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)

NCT02564055
completedphase_2

A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis

NCT02564042

Clinical Trials (4)

Showing 4 of 4 trials
NCT03202004Phase 3

GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis

Withdrawn
NCT03201978Phase 1

A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects

Withdrawn
NCT02564055Phase 2

A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)

Completed
NCT02564042Phase 2

A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4